All Outputs (3)

Hepatic insulin resistance and related obesity: highlighting the ameliorative role of nutraceuticals, dietary intervention, and pharmaceuticals. (2023)
Journal Article
RAMADAN, N.M., BARBOSA, P.O., ABO EL-MAGD, E.F., ERAKY, S.M. and AL-GAYYAR, M.M.H. 2023. Hepatic insulin resistance and related obesity: highlighting the ameliorative role of nutraceuticals, dietary intervention, and pharmaceuticals. Frontiers in Pharmacology [online], 14, article 1266168. Available from: https://doi.org/10.3389/fphar.2023.1266168

Insulin resistance (IR) is the unifying denominator of all obesity-related metabolic abnormalities. It possesses a definite higher risk of developing type 2 diabetes mellitus and non-alcoholic fatty liver disease (NAFLD). NAFLD is intimately linked t... Read More about Hepatic insulin resistance and related obesity: highlighting the ameliorative role of nutraceuticals, dietary intervention, and pharmaceuticals..

Addressing social determinants of health in the wake of the COVID-19 pandemic: urgent need to consider policy and practice in relation to pharmacy's contribution. (2022)
Journal Article
CUNNINGHAM, S., JEBARA, T. and DOUGLAS, F. 2022. Addressing social determinants of health in the wake of the COVID-19 pandemic: urgent need to consider policy and practice in relation to pharmacy's contribution. International journal of pharmacy practice [online], 30(5), pages 401-403. Available from: https://doi.org/10.1093/ijpp/riac072

World Health Organization reports highlight health inequalities and social determinants of health (SDoH), and the need for their consideration in strategic health plans. The coronavirus pandemic has exacerbated these issues and government imposed COV... Read More about Addressing social determinants of health in the wake of the COVID-19 pandemic: urgent need to consider policy and practice in relation to pharmacy's contribution..

New insights into the yin and yang of the endocannabinoid system in health and disease. (2016)
Journal Article
WAINWRIGHT, C. 2016. New insights into the yin and yang of the endocannabinoid system in health and disease. British journal of pharmacology [online], 173(7), pages 1113-1115. Available from: https://doi.org/10.1111/bph.13451

This article is part of a themed section on Endocannabionoids, of which the author is guest editor. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v173.7/issuetoc.